BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 27865365)

  • 1. Implications of cancer stem cells in developing therapeutic resistance in oral cancer.
    Naik PP; Das DN; Panda PK; Mukhopadhyay S; Sinha N; Praharaj PP; Agarwal R; Bhutia SK
    Oral Oncol; 2016 Nov; 62():122-135. PubMed ID: 27865365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Resistance Driven by Cancer Stem Cells and Their Niche.
    Prieto-Vila M; Takahashi RU; Usuba W; Kohama I; Ochiya T
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral Cancer Stem Cells Microenvironment.
    Naik PP; Panda PK; Bhutia SK
    Adv Exp Med Biol; 2017; 1041():207-233. PubMed ID: 29204835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
    Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
    Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem cell (CSC) resistance drivers.
    Najafi M; Mortezaee K; Majidpoor J
    Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular mechanisms underlying the therapeutic resistance of cancer stem cells.
    Kim JK; Jeon HY; Kim H
    Arch Pharm Res; 2015 Mar; 38(3):389-401. PubMed ID: 25502807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.
    Ranji P; Salmani Kesejini T; Saeedikhoo S; Alizadeh AM
    Tumour Biol; 2016 Oct; 37(10):13059-13075. PubMed ID: 27561758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of cancer initiating/stem cells in carcinogenesis and therapy resistance in oral cancer.
    Sinha N; Mukhopadhyay S; Das DN; Panda PK; Bhutia SK
    Oral Oncol; 2013 Sep; 49(9):854-862. PubMed ID: 23876628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic and metabolic regulation of breast cancer stem cells.
    Liu HX; Li XL; Dong CF
    J Zhejiang Univ Sci B; 2015 Jan; 16(1):10-7. PubMed ID: 25559951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell division patterns and chromosomal segregation defects in oral cancer stem cells.
    Kaseb HO; Lewis DW; Saunders WS; Gollin SM
    Genes Chromosomes Cancer; 2016 Sep; 55(9):694-709. PubMed ID: 27123539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of autophagy in the cross-talk between epithelial-mesenchymal transitioned tumor cells and cancer stem-like cells.
    Marcucci F; Ghezzi P; Rumio C
    Mol Cancer; 2017 Jan; 16(1):3. PubMed ID: 28137290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EMT, CTCs and CSCs in tumor relapse and drug-resistance.
    Mitra A; Mishra L; Li S
    Oncotarget; 2015 May; 6(13):10697-711. PubMed ID: 25986923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and molecular biology of cancer stem cells in melanoma: Possible therapeutic implications.
    Marzagalli M; Raimondi M; Fontana F; Montagnani Marelli M; Moretti RM; Limonta P
    Semin Cancer Biol; 2019 Dec; 59():221-235. PubMed ID: 31265892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cells (CSCs), cervical CSCs and targeted therapies.
    Huang R; Rofstad EK
    Oncotarget; 2017 May; 8(21):35351-35367. PubMed ID: 27343550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sox2 expression involvement in the oncogenicity and radiochemoresistance of oral cancer stem cells.
    Chou MY; Hu FW; Yu CH; Yu CC
    Oral Oncol; 2015 Jan; 51(1):31-9. PubMed ID: 25456004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
    Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
    Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cancer Stem Cells (CSCs) as a Rational Therapeutic Cancer Target, and Screening for CSC-targeting Drugs].
    Mashima T
    Yakugaku Zasshi; 2017; 137(2):129-132. PubMed ID: 28154319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms.
    Cojoc M; Mäbert K; Muders MH; Dubrovska A
    Semin Cancer Biol; 2015 Apr; 31():16-27. PubMed ID: 24956577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer stem cells: opportunities and challenges.
    Chhabra R
    J Cancer Res Clin Oncol; 2015 Nov; 141(11):1889-97. PubMed ID: 25563493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
    Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
    Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.